STOCK-BASED COMPENSATION (Tables)

9 Months Ended

Jul. 30, 2017

STOCK-BASED COMPENSATION

Schedule of reconciliation of the number of options outstanding and exercisable

	Shares	Weighted- Average Exercise Price	Weighted- Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding at October 30, 2016	31,998	$ 16.05
Granted	2,360	33.58
Exercised	2,935	10.17
Forfeited	36	9.35
Outstanding at July 30, 2017	31,387	$ 17.93	4.8 years	$ 518,421
Exercisable at July 30, 2017	25,228	$ 14.54	3.9 years	$ 496,814

Schedule of weighted-average grant date fair value of stock options granted and the total intrinsic value of options exercised

	Three Months Ended				Nine Months Ended
	July 30, 2017		July 24, 2016		July 30 2017		July 24, 2016
Weighted-average grant date fair value	$	-	$	7.46	$	6.41	$	7.82
Intrinsic value of exercised options	$	12,385	$	7,895	$	73,473	$	111,111

Schedule of weighted-average assumptions used to calculate fair value of each option award

	Three Months Ended		Nine Months Ended
	July 30, 2017	July 24, 2016	July 30, 2017	July 24, 2016
Risk-free interest rate	-	1.9%	2.4%	2.1%
Dividend yield	-	1.5%	2.0%	1.5%
Stock price volatility	-	19.0%	19.0%	19.0%
Expected option life	-	8 years	8 years	8 years

Schedule of reconciliation of the nonvested shares

A reconciliation of the nonvested shares (in thousands) as of July 30, 2017, and changes during the nine months then ended, is as follows:

	Shares	Weighted- Average Grant- Date Fair Value
Nonvested at October 30, 2016	47	$	41.01
Granted	58	35.62
Vested	47	41.01
Nonvested at July 30, 2017	58	$	35.62

Schedule of the weighted-average grant date fair value of nonvested shares granted, the total fair value of nonvested shares granted, and the fair value of shares that have vested

The weighted-average grant date fair value of nonvested shares granted, the total fair value (in thousands) of nonvested shares granted, and the fair value (in thousands) of shares that have vested during the first nine months of fiscal years 2017 and 2016, are as follows:

	Nine Months Ended
	July 30, 2017		July 24, 2016
Weighted-average grant date fair value	$	35.62	$	41.01
Fair value of nonvested shares granted	2,080		1,920
Fair value of shares vested	1,920		1,920

Schedule of stock-based compensation expense, along with the related income tax benefit

	Three Months Ended				Nine Months Ended
(in thousands)	July 30, 2017		July 24, 2016		July 30, 2017		July 24, 2016
Stock-based compensation expense recognized	$	2,006	$	1,913	$	13,867	$	16,091
Income tax benefit recognized	(757)		(726)		(5,231)		(6,105)
After-tax stock-based compensation expense	$	1,249	$	1,187	$	8,636	$	9,986